Oaktree appoints banks for planned sale of SGD Pharma -sources

PARIS, Feb 12 (Reuters) - Oaktree Capital plans to sell its stake in SGD Pharma, a French company that specialises in making glass packaging for the pharmaceutical sector, and has mandated JP Morgan and Lazard to drive the process, two sources close to the deal told Reuters on Friday.